Evidence map›Paper›PMID 29790840›Full record

SynthesisPaediatrics and international child health2018

Guidelines for the treatment of severe acute malnutrition: a systematic review of the evidence for antimicrobial therapy.

Phoebe C M Williams, James A Berkley

Registry-linked trialOpen access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Paediatrics and international child health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03174236 (First Line Antimicrobials in Children With Complicated Severe Acute Malnutrition), which is not on this map. Cited by 29 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 3 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03174236 phase3unknown statusnot on this map

First Line Antimicrobials in Children With Complicated Severe Acute Malnutrition

TypeinterventionalSponsorUniversity of OxfordRan2017 to 2020Enrolled2,000ConditionsMalnutrition Severe, Antibiotic Resistance, Antibiotic ToxicityArmsCeftriaxone, Benzyl penicillin, Metronidazole, Placebo, Gentamicin
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 3 syntheses or guidelines pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Microbial genomics · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Malnutrition, poor post-natal growth, intestinal dysbiosis and the developing lung.Journal of perinatology : official journal of the California Perinatal Association · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Phoebe C M Williamsa Nuffield Department of Clinical Medicine , University of Oxford , Oxford , UK.ORCID 0000-0003-2250-0594
James A Berkleyb Kenya Medical Research Institute (KEMRI)/Wellcome Trust Research Programme , Kilifi , Kenya.ORCID 0000-0002-1236-849X
Kenya Medical Research Institute · KEUniversity of Oxford · GB

Funding

Medical Research Council MR/M007367/1Wellcome Trust
6 · The paper itself

Abstract

Background Severe acute malnutrition (SAM) affects nearly 20 million children worldwide and is responsible for up to 1 million deaths per year in children under the age of 5 years. Current WHO guidelines recommend oral amoxicillin for children with uncomplicated malnutrition and parenteral benzylpenicillin and gentamicin for those with complicated malnutrition. Because of cost pressures and increasing antimicrobial resistance, the administration of empirical antibiotics for children with SAM has recently been debated. Methods A systematic review of the current published literature was undertaken to assess the efficacy, safety, cost-effectiveness and pharmacokinetics of antimicrobial treatment of children with SAM in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Results The initial search found 712 papers, eight of which met the inclusion criteria. Quality assessment of the studies was performed as per the Grading of Recommendations Assessment, Development and Evaluation guidelines. International guidelines and clinical data registries were also reviewed which identified inconsistencies in current first- and second-line therapies and dosing regimens. Conclusion Current evidence supports the continued use of broad-spectrum oral amoxicillin for treating children with uncomplicated SAM as outpatients. There is no strong evidence to justify changing the current parenteral therapy guidelines for children admitted with complicated SAM, although they should be clarified to harmonise the dosage regimen of amoxicillin for the treatment of SAM to 40 mg/kg twice daily, and to continue parenteral antimicrobials beyond 2 days if indicated by the clinical condition.

Indexed as

Administration, OralAmoxicillinAnti-Bacterial AgentsChild, PreschoolCost-Benefit AnalysisDrug-Related Side Effects and Adverse ReactionsGuidelines as TopicHumansInfantInjections, IntramuscularSevere Acute MalnutritionWorld Health OrganizationAmoxicillinAnti-Bacterial Agentsantibiotic resistanceantibioticsantimicrobialsempirical therapySevere acute malnutrition

Identifiers

PMID29790840
PMCPMC5972636
OpenAlexW2809494828

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.